Africa continues to face substantial infectious-disease threats while operating within persistent constraints in health financing, surveillance, laboratory infrastructure, emergenc
A narrative review summarizing RSV pathogenesis, epidemiology, clinical features, and the landscape of approved vaccines and monoclonal antibodies; provides synthesis for clinical decision-making but not original trial evidence.